Navigation Links
ChemImage Works to Improve Existing Methods of Imaging Untreated Fingerprints on Paper Substrates
Date:6/4/2009

PITTSBURGH, June 4 /PRNewswire/ -- Scientists at ChemImage are pleased to report significant improvements in the ability to enhance contrast of untreated fingerprints on paper substrates. Using the CONDOR(TM) Hyperspectral Imaging System, application scientists at ChemImage have been able to apply new developments in software and hardware configurations resulting in the enhancement of more ridge detail of untreated latent prints on paper.

"The results are very promising," said John Belechak, Chief Operating Officer at ChemImage, "To compare the images of these untreated fingerprints to those that we've seen in previous publications demonstrates a noteworthy step forward in the science of latent print examination."

The CONDOR Hyperspectral Imaging System utilizes liquid crystal imaging technology, which provides fingerprint examiners with the ability to nondestructively enhance contrast between the print residue and the substrate. When combined with the powerful ChemImage Xpert(TM) software package, users have access to a significant number of image filtering algorithms. This software becomes extremely important when examining fingerprints on dark substrates or substrates with complex backgrounds.

"While our CONDOR Hyperspectral Imaging System can be used to compliment many processing techniques for fingerprints, it can also provide a means of examining untreated prints, especially if the evidence may contain DNA or includes sensitive documents or art," said Belechak.

About ChemImage

ChemImage Corporation, headquartered in Pittsburgh, is a world leader in Chemical Imaging technologies; provides instrumentation, software, lab services and expert consulting to government, industrial and academic organizations. ChemImage offers these products and services for a range of applications including defense, security, pharmaceuticals, forensics and biomedical diagnostic research. Its state-o
'/>"/>

SOURCE ChemImage Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions
2. Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed
3. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
4. Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy
5. ChemAxon Launches Marvin and JChem Version 5.2; Web Services, native .NET API, Homology Groups, 3D Alignment and Structural Frameworks
6. Corgenix to Exhibit AspirinWorks(R) Test at ACC.09
7. MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop
8. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
9. SenesTech Scientists Attend International Workshop on Fertility in New Zealand
10. Proximity Systems LAN Based Electronic Lock Management System Offers Increased Security, Efficiency and Reporting Capability for Wall-Mounted WorkStations
11. Enrichment of Genomic Loci for Targeted Sequencing Application Is Focus of 2009 AGBT Conference Workshop

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... 19 Dr. Mate Hidvegi, inventor of ... press release issued on November 17 by Biropharma...g false and self-serving statements about its U.S....gi stated from his office in Budapest, Hungary: ,... does not apply to AveULTRA, www.aveultra.com ,...
(Date:11/19/2009)...19 Spherix Incorporated ...r diabetes therapy, and a provider of technical an...nt, biotechnology and pharmaceutical companies, to...ing of Shareholders. ,, At the meeting, shareho...cted the following members to the Board of Directo...
(Date:11/19/2009)...RNewswire/ - Aegera Therapeutics Inc. announced to...d Phase 2B study of AEG35156, a targeted antisense... oncology indications. ,, The study, entitled "...nked Inhibitor of Apoptosis (XIAP) Antisense AEG35... and Idarubicin in AML Following Failure of a Sing...
(Date:11/19/2009)...nd is honored by latest award for revolutionary he...PRWEB) November 16, 2009 -- Popular Science Magazi...ring aid from InSound Medical a winner of its cove...ategory.    Chosen from thousa...in the hearing canal for up to four months while p...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
... Even with layoff announcements...employment continued to increase in September, gai...th it seemed like no one was searching for those n...ocus) October 31, 2008 -- Strong growth continues ...0 jobs created each month. Even with layoff announ...
...GO, Oct. 30 Accumetrics, Inc. has appointed,Timot...ecutive Officer. Mr.,Still has been serving in the... for the company since earlier this year., "Tim h...and startup,experience for our Board," says Tony A... Executive Chairman of the Board at Accumetrics. "...
...GE, Mass., Oct. 30 Idenix,Pharmaceuticals, Inc. (...ed,in the discovery and development of drugs for t...iseases, today reported unaudited financial result...ember 30, 2008. At,September 30, 2008, Idenix,s ca...aled approximately $60.1 million., 2008 Year-to-D...
Other Biology Technology:The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3Timothy I. Still Appointed CEO at Accumetrics 2Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 2Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 3Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 4Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 5Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 6Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 7
(Date:11/19/2009)...ISON This week, scientists are revealing the gene... cereal crops. Corn, or maize, has one of the most...ersity of Wisconsin-Madison genomicist David Schwa...rticle in the journal Science . , "The maize ge... dead-ends that have troubled would-be sequencers ...
(Date:11/19/2009)... , WALL, N.J., Nov. 19 /PRNewswire-FirstCal...ard: BKYI), a leader in wireless public safety and...announced that the Special Shareholder Meeting hel...en because a quorum was not present. ,, (Logo: ...EYLOGO) ,, While an impressive 99.3% of the 35 ...
(Date:11/19/2009)...ACA, N.Y. - A new study of maize has identified th...le portions of the genome. New techniques may allo...iation to identify desirable traits and create new..., Publishing in the Nov. 19 issue of Science , t...at Cornell, have identified the first map of haplo...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New map of variation in maize genetics holds promise for developing new varieties 2Dendreon Announces Webcast Presentations at Upcoming Investor Conferences 12482 1Bart Peterson to Join Lilly Leadership Team 48032 1Bart Peterson to Join Lilly Leadership Team 48032 2Bart Peterson to Join Lilly Leadership Team 48032 3Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting 12481 1Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting 12481 2
...p revolutionary drug delivery methods that are mor...ions of patients. , Chemists at The University of... drugs in plastics, using methods that do not dama...ical drugs which are at the cutting edge of modern...ting drugs can use high temperatures and harsh sol...
...ional (CI) today announced a partnership with Toyo...than 4,000 acres of the Philippines Peablanca Prot...e Northeastern part of one of the nations main isl...l communities will receive additional benefits fro...ment. , The site was chosen to launch the partner...
...he Neanderthals died out because of competition wi...tic conditions. Although scientists have gained in...icult to pinpoint the climatic character at the ti...y an international team of researchers, published ...eveloped a breakthrough approach to address this i...
Other Biology News:Using green chemistry to deliver cutting-edge drugs 2Using green chemistry to deliver cutting-edge drugs 3Using green chemistry to deliver cutting-edge drugs 4Conservation International and Toyota partner to protect Philippines' rain forests 2Conservation International and Toyota partner to protect Philippines' rain forests 3Climate -- no smoking gun for Neanderthals 2
Rat Anti-Mouse Axl Monoclonal Antibody, Unconjugated, Clone 175128 from R&D Systems
Rabbit Anti-Human RXRA Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Human M-CSF from BioVision
Mouse Anti-Human IL-19 Monoclonal Antibody, Unconjugated, Clone 152112 from R&D Systems
Biology Products: